Auto and Auto Parts Makers Announce Annual Stockholder Meeting Results, Upcoming Presentations, Quarterly Dividends, and Earnings Results - Analyst Notes on Tesla, Ford, Autoliv, Toyota and AAM
Editor Note: For more information about this release, please scroll to bottom.
NEW YORK, June 2, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding Tesla Motors, Inc. (NASDAQ: TSLA), Ford Motor Co. (NYSE: F), Autoliv, Inc. (NYSE: ALV), Toyota Motor Corporation (NYSE: TM) and American Axle & Manufacturing Holdings Inc. (NYSE: AXL). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3187-100free.
--
Tesla Motors, Inc. Analyst Notes
On May 28, 2014, Tesla Motors, Inc.'s (Tesla) stock declined 0.62%, ending the day at $210.24. Over the previous three trading sessions, shares of Tesla rose 2.62% compared to the Nasdaq Composite which climbed 1.70% during the same period. The full analyst notes on Tesla are available to download free of charge at:
http://www.analystsreview.com/TSLA.pdf/Register
--
Ford Motor Co. Analyst Notes
On May 28, 2014, Ford Motor Co. (Ford) announced that it will participate in Deutsche Bank 5th Annual Global Industrials and Basic Materials Conference in Chicago on Wednesday, June 4, 2014. The Company informed that it's Executive Vice President and President of The Americas, Joe Hinrichs, will present at 2:40 p.m. ET. (1:40 p.m. CT) and the 35 minute presentation will include a question and answer session. Ford stated that a listen-only audio webcast and presentation materials will be available at its website. The full analyst notes on Ford are available to download free of charge at:
http://www.analystsreview.com/F.pdf/Register
--
Autoliv, Inc. Analyst Notes
On May 6, 2014, Autoliv, Inc.'s (Autoliv) Board of Directors declared a quarterly dividend of $0.54 per share for Q3 2014.The Company stated that the dividend will be payable on September 4, 2014 to its shareholders on record on the close of business on August 20, 2014. The Company also announced that at its Annual General Meeting of Stockholders, which was held on May 6, 2014, its stockholders approved the following proposals: the re-election of Mr. Jan Carlson and James M. Ringler as directors of the Board for a regular three-year term ending at the 2017 AGM; the non-binding, advisory resolution to approve the Company's 2013 executive compensation; an amendment to the Company's Restated Certificate of Incorporation; and the ratification of the appointment of Ernst & Young AB as the Company's independent auditing firm for the fiscal year ending December 31, 2014. The full analyst notes on Autoliv are available to download free of charge at:
http://www.analystsreview.com/ALV.pdf/Register
--
Toyota Motor Corporation Analyst Notes
On May 28, 2014, Toyota Motor Corporation (Toyota) reported that it will start trial leasing of newly developed clinical research versions of its "Walk Training Assist" and "Balance Training Assist" robots to 20 medical facilities in Japan this autumn. According to Toyota, the clinical research versions are improved versions of those announced in 2011 as part of the Toyota Partner Robot series and are aimed to help in the rehabilitation of patients who find it difficult to walk or maintain balance due to illness or injury. The Company stated that the newly developed clinical research models will be showcased at the 51st Annual Meeting of The Japanese Association of Rehabilitation Medicine, to be held from June 5, 2014 to June 7, 2014 at the Nagoya Congress Center. The full analyst notes on Toyota are available to download free of charge at:
http://www.analystsreview.com/TM.pdf/Register
--
American Axle & Manufacturing Holdings Inc. Analyst Notes
On May 2, 2014, American Axle & Manufacturing Holdings Inc. (AAM) reported its financial results for Q1 2014. For the quarter, AAM's net sales increased 13.7% YoY to $858.8 million. Net income was $33.6 million or $0.44 per diluted share, compared to $7.3 million or $0.10 per diluted share in Q1 2013. "AAM's financial results in the first quarter of 2014 reflect strong sales growth that continues to outpace the industry," said AAM's Chairman, President and CEO, David C. Dauch. "AAM's top priority in 2014 is to flawlessly launch our new business backlog which will drive higher profitability, improve free cash flow generation and enhance business diversification for our fast-growing company. We remain committed to delivering world-class quality products, maintaining operational excellence at every one of our 35 global facilities and demonstrating technology leadership by continuing to develop innovative driveline solutions for the global automotive market." The full analyst notes on AAM are available to download free of charge at:
http://www.analystsreview.com/AXL.pdf/Register
--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com .
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com .
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article